New Oral GLP-1 Pill Delivers 12% Weight Loss Without Injections: What August 2026’s Breakthrough Means for Americans
An August 10, 2026 trial found aleniglipron, a new oral GLP-1 small molecule pill, delivers up to 12% weight loss in 36 weeks without injections. A 40-year pharmacist explains the science, how it compares to Ozempic and Wegovy, and what it means for the millions of Americans who need obesity treatment.